http://www.bluebirdbio.com
bluebird bio, Inc. Company Intro
Headquartered in Cambridge, MA, bluebird bio develops pioneering gene therapies for severe genetic diseases and cancers. Learn more at bluebirdbio.com.
Industry
Healthcare
bluebird bio, Inc. Headquaters
60 Binney Street
Cambridge,02142
United States
bluebird bio, Inc. Share price
14 Sep 2022 08:47 GMT
$6.97
-0.34 (-4.65 %)
bluebird bio, Inc. Market cap
$511.318 M
WMC RANKING
2023
bluebird bio, Inc. # 37
BiotechnologyLatest bluebird bio, Inc. News
08 Feb 2023
T-cell Therapy Market is Estimated to Grow at a CAGR of 25.2 ...
... Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, Celgene Corporation
08 Feb 2023
Could this be the case of a blown-up long-term opportunity ...
bluebird bio Inc. [NASDAQ: BLUE] stock has seen the most recent analyst activity on August 05, 2022, when Barclays upgraded its rating to a Equal Weight.
08 Feb 2023
Bacterial And Plasmid Vectors Global Market Report
... Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad ... and LentiGlobin a gene therapy by Bluebird Bio designed to increase the...
WMC Market Score
WMC Market to Revenue Score
bluebird bio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| bluebird bio, Inc. | USD | $241,665 | $888,833 | $-621,892 | $5,113M | 37 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total bluebird bio, Inc. Social Followers vs Top 4 Industry Competitors
bluebird bio, Inc. Post vs Top 4 Industry Competitors
bluebird bio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
bluebird bio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
bluebird bio, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| bluebird bio, Inc. | 2.63 | 39.40 | 100 | 0 | 0 | 0 | 79.26 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 8.74 | 22 | 0 | 0 | 31.75 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 4.84 | 33 | 0 | 0 | 41.52 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 54.09 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.02 | 100 | 0 | 0 | 59.73 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
